Patterson Companies, Inc. (NASDAQ:PDCO) Shares Sold by WINTON GROUP Ltd

WINTON GROUP Ltd lessened its position in shares of Patterson Companies, Inc. (NASDAQ:PDCO - Free Report) by 57.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,205 shares of the company's stock after selling 22,090 shares during the period. WINTON GROUP Ltd's holdings in Patterson Companies were worth $500,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of PDCO. Harbour Investments Inc. purchased a new position in shares of Patterson Companies during the fourth quarter worth about $26,000. GAMMA Investing LLC boosted its position in shares of Patterson Companies by 103.0% in the 4th quarter. GAMMA Investing LLC now owns 1,340 shares of the company's stock valued at $41,000 after purchasing an additional 680 shares during the period. Anchor Investment Management LLC grew its stake in Patterson Companies by 20.5% during the 3rd quarter. Anchor Investment Management LLC now owns 2,350 shares of the company's stock worth $51,000 after buying an additional 400 shares during the last quarter. Blue Trust Inc. increased its position in Patterson Companies by 18.0% during the fourth quarter. Blue Trust Inc. now owns 2,738 shares of the company's stock worth $84,000 after buying an additional 417 shares during the period. Finally, Wilmington Savings Fund Society FSB purchased a new stake in Patterson Companies in the third quarter valued at approximately $65,000. 85.43% of the stock is owned by hedge funds and other institutional investors.

Patterson Companies Price Performance

PDCO traded up $0.02 during trading on Wednesday, reaching $31.28. 714,937 shares of the stock were exchanged, compared to its average volume of 1,057,712. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.37 and a quick ratio of 0.76. The company has a market capitalization of $2.77 billion, a price-to-earnings ratio of 18.29, a P/E/G ratio of 2.71 and a beta of 0.99. Patterson Companies, Inc. has a 1 year low of $19.45 and a 1 year high of $31.79. The business's 50 day moving average price is $31.09 and its two-hundred day moving average price is $26.73.

Remove Ads

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. StockNews.com assumed coverage on shares of Patterson Companies in a research report on Thursday, March 27th. They set a "hold" rating on the stock. Leerink Partners reissued a "market perform" rating and issued a $31.35 price objective (up from $29.00) on shares of Patterson Companies in a research note on Wednesday, December 11th. Robert W. Baird upped their price objective on shares of Patterson Companies from $25.00 to $31.00 and gave the stock a "neutral" rating in a research report on Thursday, December 12th. Stifel Nicolaus lowered their target price on shares of Patterson Companies from $25.00 to $24.00 and set a "hold" rating on the stock in a report on Thursday, December 5th. Finally, Mizuho assumed coverage on shares of Patterson Companies in a report on Wednesday, December 4th. They set a "neutral" rating and a $23.00 price target for the company. Eleven analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $26.57.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.